Recent Updates
Recently added Catalysts
QTI Positive Sentiment

QT Imaging Secures Medicare Outpatient Reimbursement for QTscan®, Effective January 2027

Monday, November 9, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: QT Imaging announced that CMS will provide separate Medicare reimbursement for QTscan examinations starting January 1, 2027. This classification acknowledges the innovative, radiation-free imaging technology developed by QT Imaging. The decision is expected to enhance breast health management and accessibility for patients.

Market Sentiment Analysis

POSITIVE FACTORS

  • Medicare reimbursement for QTscan effective January 2027.
  • QT Imaging's technology is recognized for its innovation.
  • The classification supports breast health management.

Full Press Release Details

PETALUMA, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that the Centers for Medicare & Medicaid Services (CMS) has established a separately payable Medicare hospital outpatient classification for diagnostic QTscan® examinations, effective January 1, 2027. CMS recognized that QTscan diagnostic s

Frequently Asked Questions

What is QTscan?

QTscan is a diagnostic examination using innovative, radiation-free imaging technology.

When will Medicare reimburse QTscan?

Medicare reimbursement for QTscan will start on January 1, 2027.

Who announced the Medicare reimbursement?

QT Imaging announced the Medicare reimbursement for QTscan.

What is the significance of this reimbursement?

This reimbursement enhances accessibility to breast health management for patients.

ShareAdd on Google
Tags: QTI QT Imaging Medicare breast health diagnostic imaging
Last updated: Nov 9, 2026

Biotech snapshot

Cash runway
$11M liquidity · $2M/mo burn
~4 mo
High dilution risk